Results 231 to 240 of about 747,425 (295)

Piloting the options assessment toolkit with national malaria programme leaders from the Asia-Pacific countries: a meeting report. [PDF]

Malar J
Shrestha M, Acharya S, Neukom J, Lhazeen K, Thang ND, Habib MN, Wini L, Tobgyel T, Wangchuk K, Rekol H, Dysoley L, Sovannaroth S, Simatuopang M, Prameswari HD, Surya A, Ring Z, Khan MQ, Khamlome B, Hamid MHA, Mahato RK, Thapa T, Juangco SA, Lee HI, Shin HI, Gunasekera K, Aluthwera C, Sudathip P, Timpontree R, Canh HD, Cheung S, Haroon MZ, Acharya S, Commons RJ, Adhikari B, Ruwanpura V, Hein PS, Sharma A, Aung PP, Valecha N, Thriemer K, Lynch CA.   +40 more
europepmc   +1 more source

Anti‐CD19 CAR T Cells in Autoimmune Encephalitis: Inflammation Controlled, Neurodegeneration Unchecked?

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Just recently, successful chimeric antigen receptor (CAR) T cell therapy was reported in the first patient with refractory, anti‐diacylglycerol lipase alpha (DAGLA) antibody‐mediated autoimmune encephalitis, achieving partial clinical remission.
Dimitrios Mougiakakos, Marwa Al‐Dubai, Denise Walther, Dominic Borie, Jan D. Lünemann, Marc Pawlitzki, Sven G. Meuth, Solveig Henneicke, Stefan Vielhaber, Stefanie Schreiber   +9 more
wiley   +1 more source

Considering Opportunities and Challenges When Implementing the Model Master File Framework - a Meeting Report. [PDF]

Pharm Res
Tsakalozou E, Fang L, Skoda E, Nicholas T, Kollipara S, Ren K, Grosser S, Rege B, Roy P, Zhu H, Zhao L.   +10 more
europepmc   +1 more source

CAR T‐Cell Therapy in Neurology: A Scoping Review of Neuro‐Oncology, Autoimmune Diseases & Neurotoxicity

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Chimeric antigen receptor (CAR) T‐cell therapy has been investigated in neurological diseases, encompassing both central nervous system malignancies and autoimmune disorders, thereby extending its application beyond hematological cancers.
Omar Alqaisi, Mohammed Dibas, Patricia Tai, Ala Dibas, Osama Souied, Suhair Al‐Ghabeesh   +5 more
wiley   +1 more source

Moving towards high-dose primaquine or single-dose tafenoquine for Plasmodium vivax treatment in Cambodia: a meeting report from dissemination of results of the EFFORT trial to stakeholders. [PDF]

Malar J
Dysoley L, Cassidy-Seyoum S, Adhikari B, Dahal A, Phoumen N, Srey S, Phalla T, Vonn P, Engrkruy B, Sovanarath O, Mengkea H, Rathana P, Makara I, Heng PK, Heng Y, Khlok H, Pong K, Moeng T, Vantha S, Soviet U, Ravuth R, Bunreth V, Vannak K, Sokhann M, Kimmen K, Dy K, Samol S, Lo K, Sokunthea N, Kry H, Kanha L, Naren L, Oum S, Sovann Y, Channavuth R, Bunmeng C, Hughes J, Brindle H, Hu Y, Peng S, Mardi P, Chanry I, Preap S, Heoy S, Sabawoon F, Sokha T, Ringwald P, Lynch CA, Price RN, Tripura R, von Seidlein L, Devine A, Thriemer K.   +52 more
europepmc   +1 more source

Spatial and Volumetric Characteristics of Glioblastoma: Associations With Clinical Presentation and Survival

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective We aim to comprehensively analyze how regional tumor and edema characteristics are associated with clinical presentations and survival outcomes in a large cohort of glioblastoma patients. Methods Patients with IDH‐wildtype glioblastoma who received brain MRI from 2010 to 2023 were included.
Daniel J. Zhou, Marc Jaskir, Julian Gal, Yombe Fonkeu, Christos Davatzikos, MacLean P. Nasrallah, Jose Garcia, Rubo Xing, Stephen J. Bagley, Arati Desai, Richard E. Phillips, Steven Tobochnik, Colin A. Ellis, James J. Gugger, Nishant Sinha, Joel M. Stein, Kathryn A. Davis   +16 more
wiley   +1 more source

Meeting Report on the Symposium Organized to Celebrate the 40th Anniversary of the French Society for Cell Biology. [PDF]

Biol Cell
Niedergang F, Chabrier R, Tardieux I.
europepmc   +1 more source

MOGAD Is the Most Common Cause of Isolated Optic Neuritis in Children

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objectives The study aimed to characterize the clinical features, etiologies, and outcomes of isolated, first‐time pediatric ON in the post‐MOG‐IgG era. Methods This was a single‐center retrospective cohort study at Texas Children's Hospital of patients diagnosed with first‐time ON between 2018–2024, with follow‐up data collected through 2025.
Chaitanya Aduru, Akansha Chandrasekar, Kyla Blasingame, Jonathan Rosen, Jesse M. Levine, Karla Salazar, Madhuri Chilakapati, Rod Foroozan, Victoria Hardwick, Jonathan M. Yarimi, Nikita Shukla, Timothy E. Lotze, Kristen S. Fisher, Alexander J. Sandweiss   +13 more
wiley   +1 more source

Meeting report: the inaugural muscle biology and cachexia conference at the University of Houston, May 18-20, 2025, Houston, Texas, USA. [PDF]

Front Physiol
Chen J, Brotto M, Darabi R, Kumar A.
europepmc   +1 more source

Comprehensive Characterization of 98 Chinese Cases of Genetic Creutzfeldt‐Jakob Disease With T188K Mutation

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To characterize the demographic, clinical, and laboratory features of the Chinese patients of genetic Creutzfeldt‐Jakob disease with T188K variant (T188K‐gCJD), the most common subtype of genetic prion diseases (gPrDs) in China. Methods In this nationwide retrospective study, data from 98 genetically confirmed T188K‐gCJD patients ...
Chun‐Jie Li, Dong‐Lin Liang, Li‐Ping Gao, Wei‐Wei Zhang, Wei Zhou, A. Ruhan, Bing Xu, Run‐Dong Cao, Kang Xiao, Cao Chen, Qi Shi, Xiao‐Ping Dong   +11 more
wiley   +1 more source